聚合体介导的Cbl-b沉默激活T细胞对抗固体瘤
Guanhong Cui1, Yu Shao2, Junyao Wang2
1Biomedical Polymers Laboratory, College of Chemistry, Chemical Engineering and Materials Science, and State Key Laboratory of Radiation Medicine and Protection, Soochow University, Suzhou, 215123, P. R. China. xucc@suda.edu.cn.
Biomaterials science
|February 28, 2025
概括
在T细胞中沉默卡西塔斯B系淋巴瘤原瘤基因b (Cbl-b) 增强了抗瘤免疫力. 这种新的策略使用聚合体来输送siRNA,增强T细胞功能并抑制癌症免疫疗法的瘤进展.
科学领域:
- 免疫学 免疫学 免疫学
- 纳米技术纳米技术
- 在瘤学瘤学.
背景情况:
- 对于有效的癌症免疫疗法,T细胞功能至关重要.
- 卡西塔斯B系淋巴瘤原瘤基因b (Cbl-b) 作为细胞内检查点,可以抑制T细胞活性.
- 准Cbl-b提供了一种潜在的策略,可以增强抗瘤免疫反应.
研究的目的:
- 通过沉默Cbl-b开发和评估一种体内T细胞激活策略.
- 评估聚合体传递的siRNA向cblb在对抗固体瘤中的有效性.
- 调查基因沉默对T细胞功能和瘤进展的影响.
主要方法:
- 开发了聚合体,以有效地加载和传递siRNA向cblb.
- 向初级T细胞和瘤模型注射聚合体-siRNA复合体in vitro和in vivo.
- 在B16-F10和LLC模型中评估了基因沉默,IL-2受体CD25表达,T细胞耗尽标志物和瘤进展.
主要成果:
- 成功地抑制了初级T细胞中的
基因表达,增强了CD25表达和T细胞功能. - 在B16-F10和LLC模型中证明有效抑制瘤进展.
- 观察到瘤内T细胞效应者的增加和Treg细胞的减少,以及外围T细胞效应者的增加.
结论:
- 在T细胞中通过聚合体介导的基因沉默是癌症免疫治疗的有前途的方法.
- 这一策略增强了T细胞的激活和功能,从而提高了抗瘤能力.
- 这些发现支持了准Cbl-b等细胞内检查点的潜力,以克服瘤免疫逃避.
相关概念视频
Tumor Immunotherapy
461
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
461
Cytotoxic T Cells-mediated Immune Response
825
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
825
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
Abnormal Proliferation
4.4K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.4K
T Cell Activation and Clonal Selection
623
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
623
B Cell Activation and Differentiation
1.4K
The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
1.4K


